Clinical trial · Interventional
Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant
Implementation of an Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant: Pilot Feasibility Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
After the initial monitoring period during hospitalization and isolation, patients with recent transplants are regularly monitored in monthly consultations but are still fragile, immunosuppressed and undergoing many treatments. The implementation of an outpatient assistance program for transplant patients should be feasible and allow for the improvement in medical-psycho-social care for the patients during this fragile and risky period, improve the satisfaction and quality of life for these transplant patients and assist in their socio-professional and familial reintegration.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Neoplasms | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Outpatient assistance program for transplant patients (AMA-ALLO) based on a "navigation" nurse | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- outpatient assistance program
- interventionNames
- Other: Outpatient assistance program for transplant patients (AMA-ALLO) based on a "navigation" nurse
Primary outcomes (1)
- measure
- Rate of patients with all the navigation nurse intervention files received at 100%
- timeFrame
- 12 months
- description
- Rate of patients with all the navigation nurse intervention files received at 100%. A file is received at 100% if the 4 following tasks are fully completed: 1. \- patient called by nurse (and response from the patient at the set telephone appointment) 2. \- completion of medical-psycho-social questionnaire (AMA-ALLO phone call form) by nurse with the patient's responses 3. \- information and transmission of questionnaire results by nurse to the transplant physician 4. \- physician/nurse decision for potential intervention (specialized consultation, consultation with the transplant physician, hospitalization, modification of treatments, additional exams to carry out, etc.)
Secondary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients over 18 years of age * Having received an allogeneic hematopoietic stem-cell transplant * In full remission * Outpatients * Having given their informed consent for the participation in the outpatient assistance program with a navigation nurse (AMA-ALLO) at the first post-transplant consultation (starting on Day 100 +/- 10 days post-transplant i.e., when the patient passes the initial post-transplant monitoring period in hospitalization (conventional or by day) to the monitoring period in monthly medical consultations) and continuing for 12 months * Affiliated with the social security system Exclusion Criteria: * Transplant patients not having given their informed consent for inclusion in AMA-ALLO * Hospitalized or non-outpatient transplant patients * Post-transplant patients in cytological relapse * Patients under a legal regime of adult protection (guardianship, curatorship, etc.)
References
Publications (0)
Data not yet available